Tirzepatide – 16MG

Tirzepatide (GLP-1 / GIP Dual Agonist) – For Research Use Only

Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This unique mechanism distinguishes it from traditional single-agonist GLP-1 analogs and has made it a leading focus of metabolic and endocrine research.

Pre-clinical and clinical studies have explored Tirzepatide’s role in glucose regulation, lipid metabolism, and body-weight modulation, demonstrating synergistic effects from simultaneous GIP and GLP-1 receptor activation. These findings suggest potential applications in the investigation of energy balance, pancreatic signaling, and metabolic optimization.